Zymeworks (ZYME) Profit After Tax (2021 - 2026)
Zymeworks' (ZYME) quarterly Profit After Tax came in at -$44.2 million in Q1 2026, down 95.1% year-on-year from -$900.6 million in Q1 2025, and down 7.17% quarter-over-quarter from -$41.2 million in Q4 2025.
Zymeworks (ZYME) Profit After Tax (2021 - 2026) Analysis & Trends
Zymeworks has disclosed Profit After Tax across 6 years of filings, most recently posting -$44.2 million for Q1 2026.
- Profit After Tax for Q1 2026 came in at -$44.2 million, down 95.1% year-over-year; the trailing twelve-month figure through Mar 2026 was -$102.7 million (up 9.7% YoY), and the FY2025 annual result was -$81.1 million, up 33.88% from the prior year.
- Profit After Tax came in at -$44.2 million for Q1 2026 at Zymeworks, down from -$41.2 million in the prior quarter.
- In the past five years, Profit After Tax ranged from a high of $309.4 million in Q4 2022 to a low of -$72.6 million in Q1 2022.
- The 5-year median for Profit After Tax is -$29.8 million (2024), against an average of -$14.3 million.
- Across the five-year window, Profit After Tax surged 890.33% in 2022 and plunged 104.68% in 2023, its largest moves.
- Zymeworks' Profit After Tax stood at $309.4 million in 2022, then slumped by 104.68% to -$14.5 million in 2023, then tumbled by 62.31% to -$23.5 million in 2024, then slumped by 75.31% to -$41.2 million in 2025, then fell by 7.17% to -$44.2 million in 2026.
- The last three Profit After Tax figures came in at -$44.2 million (Q1 2026), -$41.2 million (Q4 2025), and -$19.6 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | -26.94 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -2.97 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 30.90 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -3.63 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -14.46 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -753,254.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.03 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -56.74 Mn |
| 10 | Zymeworks | 1.73 Bn | 1.36 Bn | - | -44.16 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -44.16 Mn |
| Dec 31, 2025 | -41.21 Mn |
| Sep 30, 2025 | -19.60 Mn |
| Jun 30, 2025 | 2.32 Mn |
| Mar 31, 2025 | -22.64 Mn |
| Dec 31, 2024 | -23.51 Mn |
| Sep 30, 2024 | -29.85 Mn |
| Jun 30, 2024 | -37.69 Mn |
| Mar 31, 2024 | -31.65 Mn |
| Dec 31, 2023 | -14.48 Mn |
| Sep 30, 2023 | -28.69 Mn |
| Jun 30, 2023 | -51.15 Mn |
| Mar 31, 2023 | -24.35 Mn |
| Dec 31, 2022 | 309.43 Mn |
| Sep 30, 2022 | -47.85 Mn |
| Jun 30, 2022 | -64.62 Mn |
| Mar 31, 2022 | -72.63 Mn |
| Dec 31, 2021 | -39.15 Mn |
| Sep 30, 2021 | -60.58 Mn |